We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Faron Pharmaceuticals Oy 13 December 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron's Financial Calendar for 2025 Company announcement, 13 December 2024 TURKU...
cals PLC on Tuesday - Turku, Finland-based developer of cancer immunotherapies - Presents full analysis of positive ph ...
Faron presents BEXMAB data at ASH Annual Meeting PR Newswire TURKU, Finland, Dec. 10, 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron Presents Full Analysis of Positive Phase 2...
Faron Pharmaceuticals Oy 10 December 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron Presents Full Analysis of Positive Phase 2 Interim Data from BEXMAB Trial at the...
Faron Pharmaceuticals Oy 02 December 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron Announces Positive Update on Recent Interactions with UK Regulatory Authorities...
Faron Pharmaceuticals Ltd on Wednesday reported positive data from an ongoing trial on patients receiving a new treat ...
Faron Pharmaceuticals Oy 27 November 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Inside Information: Faron Announces Positive Phase 2 Interim Results from BEXMAB Trial to...
Faron Pharmaceuticals Oy 11 November 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Pipeline Update: Targeting Soluble Clever-1 for Autoimmune Diseases Press release, 11...
Faron Pharmaceuticals Oy 05 November 2024 ("Faron" or "the Company") Composition of Faron Pharmaceutical's Shareholders' Nomination Board Company Announcement, 5 November 2024 TURKU...
Faron Pharmaceuticals Oy 22 October 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron's Capital Markets Day 2024 - BEXMAB follow-up data and update on drug development...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -5 | -2.94117647059 | 170 | 175 | 165 | 11754 | 168.35837531 | DE |
4 | 22.5 | 15.7894736842 | 142.5 | 195 | 142.5 | 25870 | 173.64292051 | DE |
12 | -54 | -24.6575342466 | 219 | 228 | 142.5 | 18960 | 177.84111715 | DE |
26 | 66.5 | 67.5126903553 | 98.5 | 233 | 92.5 | 37995 | 159.04136341 | DE |
52 | -135 | -45 | 300 | 324 | 89 | 39131 | 150.20621642 | DE |
156 | -105 | -38.8888888889 | 270 | 392.5 | 89 | 21486 | 195.76587428 | DE |
260 | -120 | -42.1052631579 | 285 | 560 | 89 | 32077 | 293.32304714 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions